Application form: tablets, capsules
Indication group: nonsteroid antiphlogistics and antirheumatics
Active substance: Diclofenacum natricum 25 mg
Pregnancy and lactation: VERAL 25 mg should not be used during pregnancy. As with other non-steroidal anti-inflammatory drugs, VERAL 25 mg should not be used during the last three months of pregnancy, as this could result in harm to the unborn baby or birth problems. VERAL 25 mg can cause problems with conception, so do not take this medicine if you are planning to become pregnant or have problems with conception.
minimum amount for dispatch: Diclofenac counteracts formation and effect of the chemical transmitters significant for inflammation development and pain inception in the body; it has an anti-inflammatory and analgetic effect. By its effect on blood platelets, it also reduces formation of blood clots. Diclofenac absorbs well from the preparation Diclofenac AL 25, it usually reaches the highest blood level after 2 - 3 hours, and the effect persists for several hours so that it is sufficient to use it twice or three times a day.
Recommended dosage: Adults and adolescents over 15 years Start treatment with 1 tablet when symptoms occur. If necessary, continue treatment with 1 tablet every 4-6 hours. Do not take more than 3 tablets per 24 hours. Do not exceed the indicated dose. If VERAL 25 mg symptoms do not improve or worsen within 3 days, consult your doctor for further use. Do not take VERAL for more than 7 days without consulting your doctor. The dose may be increased to 4–6 tablets daily in 2-3 divided doses on the doctor's recommendation. Children and adolescents under 15 years Children from 20 kg body weight are given 1 tablet twice a day in juvenile idiopathic arthritis, and children from 30 kg 1 tablet 3 times a day.
Manufacturer: Herbacos Recordati s.r.o., Pardubice, Czech Republic
|SUKL název||VERAL 25MG TBL ENT 30|